98 related articles for article (PubMed ID: 8820667)
1. [The resistance of Francisella tularensis to the bactericidal action of normal serum as a criterion for evaluating the virulence of the bacterium].
Pavlovich NV; Sorokin VM; Blagorodova NS
Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):7-10. PubMed ID: 8820667
[TBL] [Abstract][Full Text] [Related]
2. Francisella tularensis resistance to bactericidal action of normal human serum.
Sorokin VM; Pavlovich NV; Prozorova LA
FEMS Immunol Med Microbiol; 1996 Mar; 13(3):249-52. PubMed ID: 8861038
[TBL] [Abstract][Full Text] [Related]
3. [The capacity of avirulent forms of Francisella tularensis for dissemination and proliferation in the host body].
Tsimbalistova MV; Pavlovich NV; Sorokin VM; Tynkevich NK
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):10-3. PubMed ID: 8701638
[TBL] [Abstract][Full Text] [Related]
4. [Interaction of S- and R-lipopolysaccharides of Francisella tularensis with lypopolysaccharide-binding protein of human serum].
Onoprienko NN; Pavlovich NV
Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):16-21. PubMed ID: 18819401
[TBL] [Abstract][Full Text] [Related]
5. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes.
Sandström G; Löfgren S; Tärnvik A
Infect Immun; 1988 May; 56(5):1194-202. PubMed ID: 3356465
[TBL] [Abstract][Full Text] [Related]
6. [The characteristics of the biological properties of capsule-free variants of Francisella tularensis].
Pavlovich NV; Mishan'kin BN; Shimaniuk NIa; Ryzhkova VV; Danilevskaia GI; Mikhalevich RV
Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):21-6. PubMed ID: 8067085
[TBL] [Abstract][Full Text] [Related]
7. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
[TBL] [Abstract][Full Text] [Related]
8. [Characterization of the recombinant strain Francisella tularensis R1A].
Kislichkin NN; Kormilitsyna MI; Meshcheriakova IS
Zh Mikrobiol Epidemiol Immunobiol; 1998; (3):3-6. PubMed ID: 9700870
[TBL] [Abstract][Full Text] [Related]
9. [The isolation of capsule-free variants of Francisella tularensis].
Pavlovich NV; Mishan'kin BN; Danilevskaia GI; Khodova VA; Ryzhkova VV; Tsimbalistova MI; Sukhar' VV
Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):7-11. PubMed ID: 8059577
[TBL] [Abstract][Full Text] [Related]
10. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
Fulop M; Mastroeni P; Green M; Titball RW
Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
[TBL] [Abstract][Full Text] [Related]
11. Macrophage toxicity and complement sensitivity of virulent and avirulent strains of Legionella pneumophila.
Caparon M; Johnson W
Rev Infect Dis; 1988; 10 Suppl 2():S377-81. PubMed ID: 3187322
[TBL] [Abstract][Full Text] [Related]
12. [The preventive activity of monoclonal antibodies specific to the lipopolysaccharide of Francisella tularensis].
Khlebnikov VS; Vetchinin SS; Grechko GK; Averina AA; Golovlev IR; Averin SF; Zhemchugov VE; Konovalov SI; Anisimov GA; Afanas'ev SS
Zh Mikrobiol Epidemiol Immunobiol; 1992; (9-10):67-70. PubMed ID: 1481610
[TBL] [Abstract][Full Text] [Related]
13. Virulence factors of Francisella tularensis.
Hood AM
J Hyg (Lond); 1977 Aug; 79(1):47-60. PubMed ID: 267668
[TBL] [Abstract][Full Text] [Related]
14. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.
Clay CD; Soni S; Gunn JS; Schlesinger LS
J Immunol; 2008 Oct; 181(8):5568-78. PubMed ID: 18832715
[TBL] [Abstract][Full Text] [Related]
15. [The characterization of Francisella tularensis mutants and subspecies by using monoclonal antibodies].
Aleshkin GI; Efanova EA; Komissarova LV; Kozlovskiĭ VN; Rozhkov EV; Zakharenko VI
Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):18-22. PubMed ID: 9027167
[TBL] [Abstract][Full Text] [Related]
16. [The C antigen of Francisella tularensis].
Sukhar' VV; Uraleva VS
Mikrobiol Zh (1978); 1992; 54(2):42-6. PubMed ID: 1374833
[TBL] [Abstract][Full Text] [Related]
17. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
Ward CK; Inzana TJ
J Immunol; 1994 Sep; 153(5):2110-21. PubMed ID: 8051416
[TBL] [Abstract][Full Text] [Related]
18. Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium.
Cherwonogrodzky JW; Knodel MH; Spence MR
Vaccine; 1994 Jul; 12(9):773-5. PubMed ID: 7975855
[TBL] [Abstract][Full Text] [Related]
19. Virulence determinants and protective antigens of Francisella tularensis.
Sjöstedt A
Curr Opin Microbiol; 2003 Feb; 6(1):66-71. PubMed ID: 12615222
[TBL] [Abstract][Full Text] [Related]
20. [The characteristics of a natural attenuated isolate of Francisella tularensis].
Kormilitsyna MI; Meshcheriakova IS
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):3-6. PubMed ID: 8701651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
